USANA Health Sciences Down Over 22%, on Pace for Largest Percent Decrease Since February 2001 -- Data Talk

Dow Jones
Oct 10, 2025

USANA Health Sciences, Inc. $(USNA)$ is currently at $20.30, down $5.94 or 22.62%

 

--Would be lowest close since Feb. 6, 2013, when it closed at $18.96

--On pace for largest percent decrease since Feb. 2, 2001, when it fell 26.09%

--Currently down five of the past six days

--Currently down two consecutive days; down 23.41% over this period

--Worst two day stretch since the two days ending Feb. 10, 2016, when it fell 24.07%

--Down 25.24% this week; worst weekly performance since the week ending March 28, 2008, when it fell 25.59%

--Down 26.3% month-to-date

--Down 43.42% year-to-date; on pace for worst year since 2022, when it fell 47.43%

--Down 85.1% from its all-time closing high of $136.25 on July 25, 2018

--Down 43.27% from 52 weeks ago (Oct. 11, 2024), when it closed at $35.79

--Down 50.82% from its 52-week closing high of $41.29 on Nov. 11, 2024

--Would be a new 52-week closing low

--Traded as low as $20.10; lowest intraday level since Feb. 7, 2013, when it hit $19.26

--Down 23.4% at today's intraday low; largest intraday percent decrease since March 28, 2008, when it fell as much as 32.26%

 

All data as of 10:49:10 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 10, 2025 10:56 ET (14:56 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10